A detailed history of Wealth Collab, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealth Collab, LLC holds 549 shares of NVS stock, worth $56,585. This represents 0.04% of its overall portfolio holdings.

Number of Shares
549
Previous 632 13.13%
Holding current value
$56,585
Previous $67.3 Million 6.15%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $8,808 - $10,033
-83 Reduced 13.13%
549 $63.1 Million
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $2,381 - $2,711
-25 Reduced 3.81%
632 $61.1 Million
Q4 2023

Apr 03, 2024

BUY
$92.27 - $101.54 $60,621 - $66,711
657 New
657 $66.3 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wealth Collab, LLC Portfolio

Follow Wealth Collab, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Collab, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Collab, LLC with notifications on news.